Navigation-guided and 3D-imaging controlled minimally invasive posterior instrumentation in patients with pyogenic thoracolumbar spondylodiscitis

Navigation-guided and 3D-imaging controlled minimally invasive posterior instrumentation in patients with pyogenic thoracolumbar spondylodiscitis - Spondylodiscitis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010843

Enrollment

Registered

2016-08-15

Start date

2016-04-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M46.4

Interventions

Group 1: We want to prospectively examine 25 patients, that we will operate with the described minimally invasive technique (A minimal invasive instrumentation of the thoracolumbar spine using a percu

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Subjects with the indication for operative treatment of pyogenic thoracolumbar spondylodiscitis (minimally invasive posterior instrumentation +/- decompression +/- vertebral body biopsy; navigation-guidance/3D-imaging).

Exclusion criteria

Exclusion criteria: •Patient not suitable for anaesthesia •Treatment with any other (surgical or conservative) procedure •Incomplete data •No study consent

Design outcomes

Primary

Measure	Time frame
Primary endpoint: Difference (vs. preoperative) Oswestry Disability Index (ODI) at 6 months	—

Secondary

Measure	Time frame
Secondary endpoints: Pain and disability postoperative, at 6 weeks, 6 months, and 12 months (ODI; Visual Analogue Scale/ VAS; Macnab criteria), quality of life (EQ-5D-3L), time to mobilization, laboratory values (leukocytes, CRP), screw misplacement (Gertzbein/ Robbins), intra-/perioperative complications, reoperations, sagittal profile angles, formation of bridging bony spurs.	—

Countries

Germany

Contacts

Public ContactEnea Thanasi

Neurochirurgie

enea.thanasi@neuro.med.uni-giessen.de0641-985-52900

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026